Surface Electromyography for Dysphonia

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Weill Cornell Medicine, New York, NY
Dysphonia+1 More
Surface Electromyography - Device
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

The investigators will conduct a pilot experiment for a novel and personalized method for voice restoration using machine learning applied to surface EMG (sEMG) signal from articulatory muscles of the face and the neck allowing recognition of silent speech. The investigators predict that the use novel personalized method for voice restoration will be feasible and successful for patients.

Eligible Conditions

  • Dysphonia
  • Aphonia

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

2 Primary · 0 Secondary · Reporting Duration: "During Procedure/use of Surface ElectroMyoGraphy"

"During Procedure/use of Surface ElectroMyoGraphy"
Percentage of Words and Numbers Correctly Identified
10 minutes after the time of intervention
Subject experience with voice restoration devices: Qualitative

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

Patients with Aphonia or Dysphonia
1 of 2
Healthy Volunteers
1 of 2
Experimental Treatment
Non-Treatment Group

100 Total Participants · 2 Treatment Groups

Primary Treatment: Surface Electromyography · Has Placebo Group · N/A

Patients with Aphonia or Dysphonia
Device
Experimental Group · 1 Intervention: Surface Electromyography · Intervention Types: Device
Healthy Volunteers
Device
PlaceboComparator Group · 1 Intervention: Surface Electromyography · Intervention Types: Device
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Surface Electromyography
2019
N/A
~90

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: "during procedure/use of surface electromyography"
Closest Location: Weill Cornell Medicine · New York, NY
Photo of New York 1Photo of New York 2Photo of New York 3
2012First Recorded Clinical Trial
1 TrialsResearching Dysphonia
91 CompletedClinical Trials

Who is running the clinical trial?

Weill Medical College of Cornell UniversityLead Sponsor
973 Previous Clinical Trials
1,351,414 Total Patients Enrolled
Anais Rameau, M.DPrincipal InvestigatorWeill Medical College of Cornell University

Eligibility Criteria

Age 18+ · All Participants · 5 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You have Aphonia or Dypshonia.
You have a documented history of dysphonia or aphonia, or a GRBAS score > 0.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.